Rosufit 5 Tablet
By Rosufit
Rx
20 Tablet in a Strip

Composition
Rosuvastatin(5mg)

Manufacturer - Ajanta Pharma Ltd
Ajanta House, Charkop, Kandivli West, Mumbai 400 067, India

Expires on or after
April, 2027

liver
When it comes to the use of Rosufit 5 Tablet, it is important to exercise caution in patients with liver disease. It may be necessary to adjust the dose of the tablet for such individuals, and therefore consulting your doctor is advised. Notably, the use of Rosufit 5 Tablet is not recommended for patients with severe liver disease or active liver disease. This cautionary approach helps ensure the safe and effective use of the medication in individuals with liver issues.

kidney
Caution – Kidney Rosufit 5 Tablet may need dose adjustment for patients with kidney disease. Avoid in severe kidney disease; consult your doctor for guidance.

alcohol
When taking Rosufit 5 Tablet, be cautious about drinking alcohol. It is recommended to seek guidance from your doctor.

driving
Rosufit 5 Tablet typically does not impact driving ability.

pregnancy
Rosufit 5 Tablet is not safe to use during pregnancy. Studies on pregnant women and animals have shown harmful effects on the developing baby. It is important to seek advice from your doctor.

breastfeeding
It is not recommended to use Rosufit 5 Tablet while breastfeeding as it may cause toxicity to the baby.
| Habit Forming | No |
| Chemical Class | Phenylpyrimidine derivatives |
| Therapeutic Class | CARDIAC |
| Action Class | HMG CoA inhibitors (statins) |
₹131
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024
